Control of blood pressure in hypertensive children and adolescents assessed by ambulatory blood pressure monitoring.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967804 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2431 (Electronic) Linking ISSN: 14712431 NLM ISO Abbreviation: BMC Pediatr Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Blood Pressure Monitoring, Ambulatory*/methods ; Hypertension*/diagnosis; Humans ; Male ; Female ; Child ; Adolescent ; Child, Preschool ; Blood Pressure ; Retrospective Studies ; Antihypertensive Agents/therapeutic use

Background: There have been few studies evaluating the control of hypertension (HT) in children. This study aimed to assess the control of HT using ambulatory blood pressure monitoring (ABPM) and to compare the parameters between the uncontrolled HT and controlled HT groups.
Methods: Hypertensive patients aged ≥ 5 years who underwent ABPM to assess the control of HT were enrolled. Demographics, office blood pressure (BP), ABPM, and echocardiographic data were collected. Controlled HT was defined using a BP goal recommended by the 2016 European Society of Hypertension guidelines.
Results: There were 108 patients (64.8% males) with a mean age of 14.3 years and 51.9% had primary HT. Controlled HT was detected in 41.1% and 33.3% by office BP and ABPM, respectively. Based on ABPM, there was a greater prevalence of controlled HT in the primary HT than the secondary HT group (44.6% vs. 21.2%, P = 0.01). In the primary HT group, BMI z-score at the last follow-up had a significant decrease in the controlled HT than the uncontrolled HT group (-0.39 vs. 0.01, P = 0.032). Primary HT was negatively associated with uncontrolled HT by ABPM. In addition, ABPM showed greater sensitivity (77.8% vs. 55.8%) and negative predictive value (80.9% vs. 70.8%) to predict LVH than those of office BP measurement.
Conclusion: Only one-third of patients achieved the BP goal by ABPM and most were in the primary HT group. Weight reduction is an important measure of BP control in patients with primary HT to attenuate the risk of LVH.
(© 2024. The Author(s).)

Kidney Int. 2021 Apr;99(4):948-956. (PMID: 33301749)
Eur J Public Health. 2009 Jun;19(3):319-25. (PMID: 19208697)
Blood Press Monit. 2012 Apr;17(2):76-9. (PMID: 22391521)
Pediatrics. 2017 Sep;140(3):. (PMID: 28827377)
Front Pediatr. 2017 May 11;5:101. (PMID: 28553631)
Pediatr Investig. 2021 Mar 22;5(1):28-32. (PMID: 33778424)
BMC Cardiovasc Disord. 2021 Oct 9;21(1):485. (PMID: 34627161)
Pediatr Transplant. 2019 Sep;23(6):e13499. (PMID: 31157501)
Kidney Int. 2021 Mar;99(3):559-569. (PMID: 33637203)
Am J Hypertens. 2012 Mar;25(3):389-95. (PMID: 22089110)
Hypertension. 2019 Jul;74(1):56-62. (PMID: 31104565)
Front Pediatr. 2017 Sep 25;5:197. (PMID: 28993801)
Blood Press Monit. 2000 Aug;5(4):211-6. (PMID: 11035862)
J Hypertens. 2016 Oct;34(10):1887-920. (PMID: 27467768)
Pediatr Nephrol. 2006 Jun;21(6):820-7. (PMID: 16703375)
Int J Nephrol Renovasc Dis. 2017 Jul 26;10:205-213. (PMID: 28794651)
Am J Hypertens. 2017 Oct 1;30(10):1039-1046. (PMID: 28575139)
Indian J Nephrol. 2015 Nov-Dec;25(6):355-61. (PMID: 26664211)
Hypertension. 2022 Nov;79(11):2583-2592. (PMID: 36043402)

Keywords: Adolescents; Ambulatory blood pressure monitoring; Children; Control of blood pressure

0 (Antihypertensive Agents)

Date Created: 20240424 Date Completed: 20240425 Latest Revision: 20240427

20240427

PMC11044297

10.1186/s12887-024-04732-z

38658852